United States· US:42806-018_fb793a0a-affa-4f9a-a5b4-aa1c84aa475e

SULINDAC

A sulindac product containing sulindac, registered in United States by Epic Pharma, LLC. The same ATC class is registered in 6 of our 19 countries.

ATC M01AB02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSULINDACATCM01AB02REGISTER NO.US:42806-018_fb793a0a…PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Sulindac is registered in 6 of 19 countries.

Countries holding a registration under ATC M01AB02 (sulindac), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose

Sulindac · ATC M01AB02

6 / 19 countries

  • Canada
  • Finlandprice
  • Franceprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sulindac costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Sulindac · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • FR France$0.48
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SULINDAC
Manufacturer
Epic Pharma, LLC
Country
United States (US)
ATC code
M01AB02
ATC class
Sulindac
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    42806-018-01
  • ndc11
    42806-018-05
  • ndc11
    42806-018-10
  • ndc11
    4280601801
    100 TABLET in 1 BOTTLE (42806-018-01)
  • ndc11
    4280601805
    500 TABLET in 1 BOTTLE (42806-018-05)
  • ndc11
    4280601810
    1000 TABLET in 1 BOTTLE (42806-018-10)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

249 interactions on record for sulindac.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sulindac · interactions on record

249 records

  • 59 severe
  • 142 moderate
  • 5 minor
  • 43 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sulindac in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulindac products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • France · Arthrocine
  • United Kingdom (Northern Ireland) · Sulindac Chemidex Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4b08332-88bf-4e6b-a125-d79c9b972938
GET /v1/drugs/c4b08332-88bf-4e6b-a125-d79c9b972938?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "150",
  "substance": "SULINDAC",
  "productndc": "42806-018",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA072710",
  "marketing_category": "ANDA"
}

See everything about sulindac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.